1. Home
  2. CUE vs NSTS Comparison

CUE vs NSTS Comparison

Compare CUE & NSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • NSTS
  • Stock Information
  • Founded
  • CUE 2014
  • NSTS 1921
  • Country
  • CUE United States
  • NSTS United States
  • Employees
  • CUE N/A
  • NSTS N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • NSTS Savings Institutions
  • Sector
  • CUE Health Care
  • NSTS Finance
  • Exchange
  • CUE Nasdaq
  • NSTS Nasdaq
  • Market Cap
  • CUE 59.5M
  • NSTS 64.0M
  • IPO Year
  • CUE 2018
  • NSTS N/A
  • Fundamental
  • Price
  • CUE $0.83
  • NSTS $12.00
  • Analyst Decision
  • CUE Strong Buy
  • NSTS
  • Analyst Count
  • CUE 2
  • NSTS 0
  • Target Price
  • CUE $3.00
  • NSTS N/A
  • AVG Volume (30 Days)
  • CUE 118.2K
  • NSTS 1.3K
  • Earning Date
  • CUE 08-12-2025
  • NSTS 08-14-2025
  • Dividend Yield
  • CUE N/A
  • NSTS N/A
  • EPS Growth
  • CUE N/A
  • NSTS N/A
  • EPS
  • CUE N/A
  • NSTS N/A
  • Revenue
  • CUE $8,286,000.00
  • NSTS $9,435,000.00
  • Revenue This Year
  • CUE N/A
  • NSTS N/A
  • Revenue Next Year
  • CUE $23.84
  • NSTS N/A
  • P/E Ratio
  • CUE N/A
  • NSTS N/A
  • Revenue Growth
  • CUE N/A
  • NSTS 69.39
  • 52 Week Low
  • CUE $0.45
  • NSTS $9.37
  • 52 Week High
  • CUE $1.99
  • NSTS $13.32
  • Technical
  • Relative Strength Index (RSI)
  • CUE 53.58
  • NSTS 45.02
  • Support Level
  • CUE $0.77
  • NSTS $12.05
  • Resistance Level
  • CUE $0.84
  • NSTS $12.25
  • Average True Range (ATR)
  • CUE 0.06
  • NSTS 0.07
  • MACD
  • CUE -0.00
  • NSTS -0.01
  • Stochastic Oscillator
  • CUE 71.90
  • NSTS 14.00

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About NSTS NSTS Bancorp Inc.

NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.

Share on Social Networks: